Clinical trial
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
NCT00076635 · InterMune, Industry · Terminated
Key facts
| NCT number | NCT00076635 |
|---|---|
| Title | An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF |
| Official title | An Open-Label Study of the Safety of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis |
| Lead sponsor | InterMune, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Lung Disease |
| Intervention type | Drug |
| Interventions | Interferon gamma-1b |
| Enrollment | 91 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2007 |
| First posted | Jan 30, 2004 |
| Last update posted | Nov 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: